View Future GrowthNorofert 過去の業績過去 基準チェック /06Norofertの収益は年間平均-18.5%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間0.4% 3.6%割合で 減少しています。主要情報-18.47%収益成長率-42.14%EPS成長率Chemicals 業界の成長39.70%収益成長率-3.61%株主資本利益率-3.00%ネット・マージン-3.20%次回の業績アップデート29 Sep 2026最近の業績更新Reported Earnings • Jun 02First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: RON9.25m (down 34% from 1Q 2025). Net income: RON480.0k (down 91% from 1Q 2025). Profit margin: 5.2% (down from 38% in 1Q 2025). The decrease in margin was primarily driven by lower revenue.お知らせ • May 19+ 2 more updatesNorofert S.A. to Report Q3, 2026 Results on Dec 03, 2026Norofert S.A. announced that they will report Q3, 2026 results on Dec 03, 2026Reported Earnings • Nov 27Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: RON14.5m (down 4.7% from 3Q 2024). Net income: RON1.38m (up RON1.85m from 3Q 2024). Profit margin: 9.5% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses.Reported Earnings • Sep 26Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: RON7.17m (down 36% from 2Q 2024). Net loss: RON4.59m (down 348% from profit in 2Q 2024).Reported Earnings • May 29First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: RON14.0m (up 20% from 1Q 2024). Net income: RON5.35m (up RON5.34m from 1Q 2024). Profit margin: 38% (up from 0% in 1Q 2024). The increase in margin was primarily driven by lower expenses.Reported Earnings • Apr 14Full year 2024 earnings released: EPS: RON0.19 (vs RON0.23 loss in FY 2023)Full year 2024 results: EPS: RON0.19 (up from RON0.23 loss in FY 2023). Revenue: RON52.6m (up 19% from FY 2023). Net income: RON3.24m (up RON7.19m from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by higher revenue.すべての更新を表示Recent updatesReported Earnings • Jun 02First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: RON9.25m (down 34% from 1Q 2025). Net income: RON480.0k (down 91% from 1Q 2025). Profit margin: 5.2% (down from 38% in 1Q 2025). The decrease in margin was primarily driven by lower revenue.お知らせ • May 19+ 2 more updatesNorofert S.A. to Report Q3, 2026 Results on Dec 03, 2026Norofert S.A. announced that they will report Q3, 2026 results on Dec 03, 2026お知らせ • Mar 24Norofert S.A., Annual General Meeting, Apr 29, 2026Norofert S.A., Annual General Meeting, Apr 29, 2026.お知らせ • Feb 25Norofert S.A. (BVB:NRF) agreed to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026.Norofert S.A. (BVB:NRF) entered into an agreement to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026. The transaction amounted to €0.1 million. The full amount will be paid by December 2026.分析記事 • Jan 17Norofert S.A.'s (BVB:NRF) Business Is Trailing The Industry But Its Shares Aren'tWith a median price-to-sales (or "P/S") ratio of close to 1.4x in the Chemicals industry in Romania, you could be...分析記事 • Dec 03Some Investors May Be Worried About Norofert's (BVB:NRF) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...Reported Earnings • Nov 27Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: RON14.5m (down 4.7% from 3Q 2024). Net income: RON1.38m (up RON1.85m from 3Q 2024). Profit margin: 9.5% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses.Reported Earnings • Sep 26Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: RON7.17m (down 36% from 2Q 2024). Net loss: RON4.59m (down 348% from profit in 2Q 2024).Valuation Update With 7 Day Price Move • Jul 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to RON3.94, the stock trades at a trailing P/E ratio of 8x. Average trailing P/E is 21x in the Chemicals industry in Europe. Negligible returns to shareholders over past year.分析記事 • Jul 15Here's Why Norofert (BVB:NRF) Has A Meaningful Debt BurdenDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Reported Earnings • May 29First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: RON14.0m (up 20% from 1Q 2024). Net income: RON5.35m (up RON5.34m from 1Q 2024). Profit margin: 38% (up from 0% in 1Q 2024). The increase in margin was primarily driven by lower expenses.分析記事 • May 24Optimistic Investors Push Norofert S.A. (BVB:NRF) Shares Up 28% But Growth Is LackingNorofert S.A. ( BVB:NRF ) shareholders have had their patience rewarded with a 28% share price jump in the last month...Valuation Update With 7 Day Price Move • May 23Investor sentiment improves as stock rises 28%After last week's 28% share price gain to RON3.69, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 18x in the Chemicals industry in Europe. Total loss to shareholders of 13% over the past year.分析記事 • May 17There Are Reasons To Feel Uneasy About Norofert's (BVB:NRF) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...New Risk • May 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RON45.4m (US$9.98m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Market cap is less than US$10m (RON45.4m market cap, or US$9.98m).New Risk • Apr 23New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m).New Risk • Apr 22New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 0% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (0% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m).Reported Earnings • Apr 14Full year 2024 earnings released: EPS: RON0.19 (vs RON0.23 loss in FY 2023)Full year 2024 results: EPS: RON0.19 (up from RON0.23 loss in FY 2023). Revenue: RON52.6m (up 19% from FY 2023). Net income: RON3.24m (up RON7.19m from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by higher revenue.分析記事 • Apr 01Norofert S.A.'s (BVB:NRF) Price In Tune With RevenuesIt's not a stretch to say that Norofert S.A.'s ( BVB:NRF ) price-to-sales (or "P/S") ratio of 1.2x seems quite...お知らせ • Mar 31Norofert S.A., Annual General Meeting, May 05, 2025Norofert S.A., Annual General Meeting, May 05, 2025.Reported Earnings • Dec 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: RON15.3m (up 11% from 3Q 2023). Net loss: RON473.8k (loss narrowed 76% from 3Q 2023).Reported Earnings • Oct 03Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: RON11.2m (up 30% from 2Q 2023). Net income: RON1.85m (up 29% from 2Q 2023). Profit margin: 17% (in line with 2Q 2023).分析記事 • Sep 19Is Norofert (BVB:NRF) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Reported Earnings • Jun 04First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: RON11.7m (down 14% from 1Q 2023). Net income: RON1.4k (down 100% from 1Q 2023). Profit margin: 0% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue.Board Change • May 02No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Non-Executive Director Marian Alexe was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.収支内訳Norofert の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BVB:NRF 収益、費用、利益 ( )RON Millions日付収益収益G+A経費研究開発費31 Mar 2635-17031 Dec 254147030 Sep 253968030 Jun 254357031 Mar 254897031 Dec 244537030 Sep 2444-47030 Jun 2443-57031 Mar 2442-67031 Dec 2344-47030 Sep 235344030 Jun 236585031 Mar 2371105031 Dec 2273115030 Sep 2276106030 Jun 226485031 Mar 2264105031 Dec 215375030 Sep 213834030 Jun 213154031 Mar 212314031 Dec 202544030 Sep 203094030 Jun 202784031 Mar 202163031 Dec 191552031 Dec 1810410質の高い収益: NRFは現在利益が出ていません。利益率の向上: NRFは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: NRFは利益が出ておらず、過去 5 年間で損失は年間18.5%の割合で増加しています。成長の加速: NRFの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: NRFは利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( 2.8% ) と比較することは困難です。株主資本利益率高いROE: NRFは現在利益が出ていないため、自己資本利益率 ( -3% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/22 12:01終値2026/06/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Norofert S.A. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Jun 02First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: RON9.25m (down 34% from 1Q 2025). Net income: RON480.0k (down 91% from 1Q 2025). Profit margin: 5.2% (down from 38% in 1Q 2025). The decrease in margin was primarily driven by lower revenue.
お知らせ • May 19+ 2 more updatesNorofert S.A. to Report Q3, 2026 Results on Dec 03, 2026Norofert S.A. announced that they will report Q3, 2026 results on Dec 03, 2026
Reported Earnings • Nov 27Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: RON14.5m (down 4.7% from 3Q 2024). Net income: RON1.38m (up RON1.85m from 3Q 2024). Profit margin: 9.5% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses.
Reported Earnings • Sep 26Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: RON7.17m (down 36% from 2Q 2024). Net loss: RON4.59m (down 348% from profit in 2Q 2024).
Reported Earnings • May 29First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: RON14.0m (up 20% from 1Q 2024). Net income: RON5.35m (up RON5.34m from 1Q 2024). Profit margin: 38% (up from 0% in 1Q 2024). The increase in margin was primarily driven by lower expenses.
Reported Earnings • Apr 14Full year 2024 earnings released: EPS: RON0.19 (vs RON0.23 loss in FY 2023)Full year 2024 results: EPS: RON0.19 (up from RON0.23 loss in FY 2023). Revenue: RON52.6m (up 19% from FY 2023). Net income: RON3.24m (up RON7.19m from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by higher revenue.
Reported Earnings • Jun 02First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: RON9.25m (down 34% from 1Q 2025). Net income: RON480.0k (down 91% from 1Q 2025). Profit margin: 5.2% (down from 38% in 1Q 2025). The decrease in margin was primarily driven by lower revenue.
お知らせ • May 19+ 2 more updatesNorofert S.A. to Report Q3, 2026 Results on Dec 03, 2026Norofert S.A. announced that they will report Q3, 2026 results on Dec 03, 2026
お知らせ • Mar 24Norofert S.A., Annual General Meeting, Apr 29, 2026Norofert S.A., Annual General Meeting, Apr 29, 2026.
お知らせ • Feb 25Norofert S.A. (BVB:NRF) agreed to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026.Norofert S.A. (BVB:NRF) entered into an agreement to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026. The transaction amounted to €0.1 million. The full amount will be paid by December 2026.
分析記事 • Jan 17Norofert S.A.'s (BVB:NRF) Business Is Trailing The Industry But Its Shares Aren'tWith a median price-to-sales (or "P/S") ratio of close to 1.4x in the Chemicals industry in Romania, you could be...
分析記事 • Dec 03Some Investors May Be Worried About Norofert's (BVB:NRF) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
Reported Earnings • Nov 27Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: RON14.5m (down 4.7% from 3Q 2024). Net income: RON1.38m (up RON1.85m from 3Q 2024). Profit margin: 9.5% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses.
Reported Earnings • Sep 26Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: RON7.17m (down 36% from 2Q 2024). Net loss: RON4.59m (down 348% from profit in 2Q 2024).
Valuation Update With 7 Day Price Move • Jul 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to RON3.94, the stock trades at a trailing P/E ratio of 8x. Average trailing P/E is 21x in the Chemicals industry in Europe. Negligible returns to shareholders over past year.
分析記事 • Jul 15Here's Why Norofert (BVB:NRF) Has A Meaningful Debt BurdenDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Reported Earnings • May 29First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: RON14.0m (up 20% from 1Q 2024). Net income: RON5.35m (up RON5.34m from 1Q 2024). Profit margin: 38% (up from 0% in 1Q 2024). The increase in margin was primarily driven by lower expenses.
分析記事 • May 24Optimistic Investors Push Norofert S.A. (BVB:NRF) Shares Up 28% But Growth Is LackingNorofert S.A. ( BVB:NRF ) shareholders have had their patience rewarded with a 28% share price jump in the last month...
Valuation Update With 7 Day Price Move • May 23Investor sentiment improves as stock rises 28%After last week's 28% share price gain to RON3.69, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 18x in the Chemicals industry in Europe. Total loss to shareholders of 13% over the past year.
分析記事 • May 17There Are Reasons To Feel Uneasy About Norofert's (BVB:NRF) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
New Risk • May 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RON45.4m (US$9.98m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Market cap is less than US$10m (RON45.4m market cap, or US$9.98m).
New Risk • Apr 23New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m).
New Risk • Apr 22New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 0% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (0% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m).
Reported Earnings • Apr 14Full year 2024 earnings released: EPS: RON0.19 (vs RON0.23 loss in FY 2023)Full year 2024 results: EPS: RON0.19 (up from RON0.23 loss in FY 2023). Revenue: RON52.6m (up 19% from FY 2023). Net income: RON3.24m (up RON7.19m from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by higher revenue.
分析記事 • Apr 01Norofert S.A.'s (BVB:NRF) Price In Tune With RevenuesIt's not a stretch to say that Norofert S.A.'s ( BVB:NRF ) price-to-sales (or "P/S") ratio of 1.2x seems quite...
お知らせ • Mar 31Norofert S.A., Annual General Meeting, May 05, 2025Norofert S.A., Annual General Meeting, May 05, 2025.
Reported Earnings • Dec 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: RON15.3m (up 11% from 3Q 2023). Net loss: RON473.8k (loss narrowed 76% from 3Q 2023).
Reported Earnings • Oct 03Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: RON11.2m (up 30% from 2Q 2023). Net income: RON1.85m (up 29% from 2Q 2023). Profit margin: 17% (in line with 2Q 2023).
分析記事 • Sep 19Is Norofert (BVB:NRF) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Reported Earnings • Jun 04First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: RON11.7m (down 14% from 1Q 2023). Net income: RON1.4k (down 100% from 1Q 2023). Profit margin: 0% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue.
Board Change • May 02No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Non-Executive Director Marian Alexe was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.